U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.103T>C (p.Cys35Arg) AND not provided

Germline classification:
not provided (1 submission)
Review status:
no classification provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000119411.9

Allele description [Variation Report for NM_000540.3(RYR1):c.103T>C (p.Cys35Arg)]

NM_000540.3(RYR1):c.103T>C (p.Cys35Arg)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.103T>C (p.Cys35Arg)
Other names:
NM_000540.3(RYR1):c.103T>C
HGVS:
  • NC_000019.10:g.38440802T>C
  • NG_008866.1:g.12103T>C
  • NM_000540.3:c.103T>CMANE SELECT
  • NM_001042723.2:c.103T>C
  • NP_000531.2:p.Cys35Arg
  • NP_000531.2:p.Cys35Arg
  • NP_001036188.1:p.Cys35Arg
  • LRG_766t1:c.103T>C
  • LRG_766:g.12103T>C
  • LRG_766p1:p.Cys35Arg
  • NC_000019.9:g.38931442T>C
  • NM_000540.2:c.103T>C
  • P21817:p.Cys35Arg
  • p.(Cys35Arg)
Protein change:
C35R
Links:
PharmGKB: 1445400910PA164749136; PharmGKB: 1445400910PA449461; PharmGKB: 1445400910PA449845; PharmGKB: 1445400910PA450106; PharmGKB: 1445400910PA450434; PharmGKB: 1445400910PA451341; PharmGKB: 1445400910PA451522; UniProtKB: P21817#VAR_005589; dbSNP: rs193922747
NCBI 1000 Genomes Browser:
rs193922747
Molecular consequence:
  • NM_000540.3:c.103T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.103T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000154318Leiden Muscular Dystrophy (RYR1)
no classification provided
not providedunknownnot provided

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownnot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.

Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Roméro N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J.

Hum Mutat. 2005 Nov;26(5):413-25.

PubMed [citation]
PMID:
16163667

Details of each submission

From Leiden Muscular Dystrophy (RYR1), SCV000154318.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024